Table 2: Physicochemical properties and stability of quaternary halomethylated ammonium iodide incorporated in Precirol® nanoparticles.

Conditions Formulations
Parameters Empty NPs PC6I
2-8 ℃° T0 Size (nm) 112.5 ± 6.5 108.3 ± 2.2
PI 0.2 ± 0.01 0.31 ± 0.03
ZP mV -25.7 ± 4.4 -16.4 ± 1.9
%EE NA 68.2 ± 0.03
%DL NA 13.7 ± 0.02
2-8 ℃° T1 size (nm) 125.5 ± 1.5 103.1 ± 1.2
PI 0.3 ± 0.2 0.3 ± 0.03
ZP mV -28.4 ± 0.5 -18.7 ± 2.8
2-8 ℃° T2 size (nm) 133.3 ± 18.2 101.3 ± 5.1
PI 0.3 ± 0.06 0.3 ± 0.04
ZP mV -18.4 ± 2.0 -8.6 ± 1.5
121℃* Size (nm) 94.7 ± 7.4 86.7 ± 6.1
PI 0.3 ± 0.01 0.2 ± 0.03
121℃* -24.6 ± 2.9 -10.8 ± 1.4
%EE NA 62.8 ± 0.01
%DL NA 12.6 ± 0.04

Data represent mean value ± SD (n = 3). PC6I: nanoparticles of Precirol® incorporating the quaternary halomethylated ammonium iodide C6I; PI: polydispersion index; ZP: Zeta potential; EE: Encapsulation efficiency; DL: Drug loading. 2-8 °C° T0: Fresh NPs; 2-8 °C°; T1: One month stored; 2-8 °C°; T2: Two month stored; NA: No apply. *during 20 min.